Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

China Biotech Week In Review: SFDA Releases 2010 Approval Data
Seeking Alpha
Sunday, October 23, 2011 - 11:58am
tags:
China, Zhuhai Hokai Medical Instruments, Simcere, Amerigen Pharma, Lundbeck, Medicilon, Shenzhen Hepalink Pharmaceutical
Mid-size biotechs making their way
Boston Globe, MA
Sunday, October 23, 2011 - 11:56am
tags:
Vertex Pharmaceuticals, Ariad Pharmaceuticals, Ironwood, Curis
Enhanced Income Strategy For Novartis AG
Seeking Alpha
Sunday, October 23, 2011 - 11:24am
tags:
Novartis
6 Cheapest Drug Manufacturers With Perfect Dividends
Seeking Alpha
Sunday, October 23, 2011 - 11:23am
tags:
Sanofi, AstraZeneca, Pfizer, Merck, Novartis, JNJ
Will Abbott's Split Unlock Shareholder Value?
Seeking Alpha
Sunday, October 23, 2011 - 11:21am
tags:
Abbott Laboratories
Amgen Leads Firms In Pancreatic Cancer Drug Chase
InvestorPlace
Sunday, October 23, 2011 - 10:54am
tags:
Amgen, Ganitumab, pancreatic cancer
Keryx Biopharmaceuticals: Volatility Could Potentially Produce Monetary Gains
Seeking Alpha
Sunday, October 23, 2011 - 10:51am
tags:
Keryx, Aeterna Zentaris, Perifisone, Zerenex
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sunday, October 23, 2011 - 10:49am
tags:
Roche, Anadys, hepatitis C, ANA773, Abbott Laboratories
Mylan's Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist Patents
Bradenton Herald, FL
Saturday, October 22, 2011 - 12:39pm
tags:
Sunovion, Perforomist, Mylan, Dey
Mylan Laboratories Inc. Third Quarter Earnings Sneak Peek
Wall St Cheat Sheet
Saturday, October 22, 2011 - 12:33pm
tags:
Mylan
Alemtuzumab (Lemtrada) Significantly Reduces Relapses in Multiple Sclerosis vs Interferon Beta-1a in a Phase III Study
Yahoo/BusinessWire
Saturday, October 22, 2011 - 12:30pm
tags:
alemtuzumab, Lemtrada, Sanofi, Genzyme, multiple sclerosis
Full of News, but Worth a 15% Gain? (Amylin)
Motley Fool
Saturday, October 22, 2011 - 12:27pm
tags:
Amylin, Byetta, diabetes, Novo Nordisk, Victoza
Cheap Stocks In A Volatile Market: J&J, Intel
Seeking Alpha
Saturday, October 22, 2011 - 12:23pm
tags:
JNJ
Abbott Said to Agree to Pay $1.3 Billion for Depakote Suits
Bloomberg
Saturday, October 22, 2011 - 12:22pm
tags:
Abbott Laboratories, Depakote, lawsuits, legal
Pharmasset Falls on Rival Abbott Hepatitis C Therapy Results
Reuters
Saturday, October 22, 2011 - 12:20pm
tags:
Pharmasset, Abbott Laboratories, hepatitis C, ABT-450, protease inhibitors, ABT-333, ABT-072
Abbott Touts $4 Billion in Drug Sales as It Pitches Spinoff
Bloomberg
Saturday, October 22, 2011 - 12:17pm
tags:
Abbott Laboratories
Lilly's Third-Quarter Results Were Mixed; Patent Cliff Represents Major Risk
Seeking Alpha
Saturday, October 22, 2011 - 12:16pm
tags:
Eli Lilly
Pfizer settlement returns funds to Wisconsin Medicaid
bizjournals
Saturday, October 22, 2011 - 12:15pm
tags:
Pfizer, legal
Checking the Quality of Hospira's Growth
Motley Fool
Saturday, October 22, 2011 - 12:14pm
tags:
Hospira
Analyst: Seattle Genetics should outperform forecasts
bizjournals
Saturday, October 22, 2011 - 12:13pm
tags:
Seattle Genetics, Adcetris, Hodgkin's lymphoma, anaplastic large-cell lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.